This inventor holds 1 USPTO granted patent. Top assignee: Inje University Industry-Academic Cooperation Foundation. Active years: 2021.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2021
Title: Seung Hun Jeong: Innovator in Pyridine Nucleoside Compounds
Introduction
Seung Hun Jeong is a notable inventor based in Busan, South Korea. He has made significant contributions to the field of medicinal chemistry, particularly through his innovative work on pyridine nucleoside compounds.
Latest Patents
His most recent patent, titled "Neopetrosides A and B, and synthesis method thereof," focuses on novel compounds obtained from marine sponges. The patent describes the extraction and fractionation process using ethanol and n-butanol to isolate Neopetroside A (NPS A) and Neopetroside B (NPS B). NPS A has shown promising results in activating oxidative phosphorylation and enhancing mitochondrial respiration in myocardial cells. Furthermore, it has demonstrated the ability to recover left ventricular pressure in ischemic reperfusion injury models, suggesting its potential as a pharmaceutical composition for treating ischemic heart disease.
Career Highlights
Seung Hun Jeong is affiliated with the Inje University Industry-Academic Cooperation Foundation, where he continues to advance his research and development efforts. His work has garnered attention for its implications in the treatment of heart diseases, showcasing his commitment to improving health outcomes through innovation.
Collaborations
He collaborates with esteemed colleagues, including Jin Woo Han and In-Sung Song, who contribute to his research endeavors and help drive forward the development of his patented compounds.
Conclusion
Seung Hun Jeong's innovative work in the field of pyridine nucleoside compounds highlights his dedication to advancing medical science. His contributions have the potential to significantly impact the treatment of ischemic heart disease, showcasing the importance of research and innovation in healthcare.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile